Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2005 1
2006 1
2007 1
2008 1
2009 3
2010 2
2011 1
2013 1
2014 2
2015 2
2016 4
2018 1
2019 3
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Receptors on Cancer Cells with Protein Toxins.
Antignani A, Ho ECH, Bilotta MT, Qiu R, Sarnvosky R, FitzGerald DJ. Antignani A, et al. Biomolecules. 2020 Sep 17;10(9):1331. doi: 10.3390/biom10091331. Biomolecules. 2020. PMID: 32957689 Free PMC article. Review.
Immunotoxins: the role of the toxin.
Antignani A, Fitzgerald D. Antignani A, et al. Toxins (Basel). 2013 Aug 21;5(8):1486-502. doi: 10.3390/toxins5081486. Toxins (Basel). 2013. PMID: 23965432 Free PMC article. Review.
Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cells.
Simon N, Antignani A, Hewitt SM, Gadina M, Alewine C, FitzGerald D. Simon N, et al. Among authors: antignani a. JCI Insight. 2019 Mar 7;4(5):e123281. doi: 10.1172/jci.insight.123281. eCollection 2019 Mar 7. JCI Insight. 2019. PMID: 30720466 Free PMC article.
'Characterization of monoclonal antibodies generated to the 287-302 amino acid loop of the human epidermal growth factor receptor'.
Ho ECH, Antignani A, Sarnovsky R, FitzGerald D. Ho ECH, et al. Among authors: antignani a. Antib Ther. 2019 Oct;2(4):88-98. doi: 10.1093/abt/tbz011. Epub 2019 Nov 29. Antib Ther. 2019. PMID: 31934685 Free PMC article.
Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies.
Weiss E, Sarnovsky R, Ho M, Arons E, Kreitman R, Angelus E, Antignani A, FitzGerald D. Weiss E, et al. Among authors: antignani a. Antib Ther. 2019 Jan;2(1):1-10. doi: 10.1093/abt/tby012. Epub 2018 Dec 27. Antib Ther. 2019. PMID: 30801054 Free PMC article.
Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737.
Fitzgerald DJ, Moskatel E, Ben-Josef G, Traini R, Tendler T, Sharma A, Antignani A, Mussai F, Wayne A, Kreitman RJ, Pastan I. Fitzgerald DJ, et al. Among authors: antignani a. Leuk Lymphoma. 2011 Jun;52 Suppl 2(Suppl 2):79-81. doi: 10.3109/10428194.2011.569961. Leuk Lymphoma. 2011. PMID: 21599608 Free PMC article. Review.
Conformation of BCL-XL upon Membrane Integration.
Yao Y, Fujimoto LM, Hirshman N, Bobkov AA, Antignani A, Youle RJ, Marassi FM. Yao Y, et al. Among authors: antignani a. J Mol Biol. 2015 Jul 3;427(13):2262-70. doi: 10.1016/j.jmb.2015.02.019. Epub 2015 Feb 27. J Mol Biol. 2015. PMID: 25731750 Free PMC article.
Characterization of the membrane-inserted C-terminus of cytoprotective BCL-XL.
Yao Y, Nisan D, Fujimoto LM, Antignani A, Barnes A, Tjandra N, Youle RJ, Marassi FM. Yao Y, et al. Among authors: antignani a. Protein Expr Purif. 2016 Jun;122:56-63. doi: 10.1016/j.pep.2016.02.010. Epub 2016 Feb 23. Protein Expr Purif. 2016. PMID: 26923059 Free PMC article.
Ranking Differential Drug Activities from Dose-Response Synthetic Lethality Screens.
Guha R, Mathews Griner LA, Keller JM, Zhang X, Fitzgerald D, Antignani A, Pastan I, Thomas CJ, Ferrer M. Guha R, et al. Among authors: antignani a. J Biomol Screen. 2016 Oct;21(9):942-55. doi: 10.1177/1087057116644890. Epub 2016 Apr 25. J Biomol Screen. 2016. PMID: 27112173
How do Bax and Bak lead to permeabilization of the outer mitochondrial membrane?
Antignani A, Youle RJ. Antignani A, et al. Curr Opin Cell Biol. 2006 Dec;18(6):685-9. doi: 10.1016/j.ceb.2006.10.004. Epub 2006 Oct 12. Curr Opin Cell Biol. 2006. PMID: 17046225 Review.
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback